103 related articles for article (PubMed ID: 15070712)
21. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
22. Still puzzling Notch signaling in B-cell malignancies.
Chiaramonte R
Leuk Res; 2006 Nov; 30(11):1331-2. PubMed ID: 16934329
[No Abstract] [Full Text] [Related]
23. Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.
Takahashi H; Feuerhake F; Monti S; Kutok JL; Aster JC; Shipp MA
Blood; 2006 Jan; 107(2):844-5. PubMed ID: 16401828
[No Abstract] [Full Text] [Related]
24. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
25. Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.
Sirivisoot S; Techangamsuwan S; Tangkawattana S; Rungsipipat A
Asian Pac J Cancer Prev; 2016; 17(6):2909-16. PubMed ID: 27356711
[TBL] [Abstract][Full Text] [Related]
26. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
28. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
29. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
[TBL] [Abstract][Full Text] [Related]
30. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
31. [Morphologic study of tonsillar B-cell lymphomas].
He MX; Zheng JM; Wu LL; Ma DL; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):127-8. PubMed ID: 17493390
[No Abstract] [Full Text] [Related]
32. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
Giménez S; Costa C; Espinet B; Solé F; Pujol RM; Puigdecanet E; García-Moreno P; Sánchez J; Gallardo F; Estrach T; García-Muret P; Romagosa V; Serrano S; Servitje O
Exp Dermatol; 2005 Dec; 14(12):883-90. PubMed ID: 16274455
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
35. Myb proteins inhibit fibroblast transformation by v-Rel.
Fu SL; Ganter B; Lipsick JS
Mol Cancer; 2006 Nov; 5():54. PubMed ID: 17081304
[TBL] [Abstract][Full Text] [Related]
36. Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.
Tiwari R; Bargmann W; Bose HR
Virology; 2011 Apr; 413(1):60-71. PubMed ID: 21345476
[TBL] [Abstract][Full Text] [Related]
37. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene.
Lossos IS; Warnke R; Levy R
Leukemia; 2002 Sep; 16(9):1857-62. PubMed ID: 12200704
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
[TBL] [Abstract][Full Text] [Related]
39. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.
Palanisamy N; Abou-Elella AA; Chaganti SR; Houldsworth J; Offit K; Louie DC; Terayu-Feldstein J; Cigudosa JC; Rao PH; Sanger WG; Weisenburger DD; Chaganti RS
Genes Chromosomes Cancer; 2002 Feb; 33(2):114-22. PubMed ID: 11793437
[TBL] [Abstract][Full Text] [Related]
40. A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation.
Adam P; Katzenberger T; Seeberger H; Gattenlöhner S; Wolf J; Steinlein C; Schmid M; Müller-Hermelink HK; Ott G
Am J Surg Pathol; 2003 Nov; 27(11):1473-6. PubMed ID: 14576483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
